default author photo

Sacha I. Rothschild

University of Basel - University Hospital Basel

Wilhelm-Klein-Strasse 27

Basel, 4025

Switzerland

SCHOLARLY PAPERS

7

DOWNLOADS

449

TOTAL CITATIONS

4

Scholarly Papers (7)

Actions:
Email selected abstracts
1.

SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small Cell Lung Cancer — A Multicentre Single-Arm Phase II Trial

Number of pages: 32 Posted: 27 Jan 2021
Sacha I. Rothschild, Alfred Zippelius, Eric I. Eboulet, Spasenija Savic Prince, Daniel Betticher, Adrienne Bettini, Martin Früh, Markus Joerger, Didier Lardinois, Hans Gelpke, Laetitia A. Mauti, Christian Britschgi, Walter Weder, Solange Peters, Michael Mark, Richard Cathomas, Adrian F. Ochsenbein, Wolf-Dieter Janthur, Christine Waibel, Nicolas Mach, Patrizia Froesch, Martin Buess, Pierre Bohanes, Gilles Godar, Corinne Rusterholz, Michel Gonzalez, Miklos Pless and Swiss Group for Clinical Cancer Research (SAKK) Group
University of Basel - University Hospital Basel, University of Basel - Department of Biomedicine, SAKK Coordinating Center, University of Basel - University Hospital Basel, Department of Oncology, HFR Fribourg – Hôpital fribourgeois, Department of Oncology, HFR Fribourg – Hôpital fribourgeois, Cantonal Hospital of St. Gallen, Cantonal Hospital of St. Gallen, University of Basel - University Hospital Basel, Cantonal Hospital Winterthur, Cantonal Hospital Winterthur, University Hospital Zurich, University Hospital Zurich, Department of Oncology, University Hospital Lausanne CHUV, Divison of Oncology/Haematology, Cantonal Hospital Graubünden, Divison of Oncology/Haematology, Cantonal Hospital Graubünden, University of Bern - Department of Medical Oncology, Department of Oncology/Haematology, Cantonal Hospital Aarau, Cantonal Hospital Baden, University of Geneva - Department of Oncology, Oncology Institute of Southern Switzerland, Division of Medical Oncology, St. Claraspital, Centre de Chimiothérapie Anti-Cancéreuse, SAKK Coordinating Center, SAKK Coordinating Center, Department of Thoracic Surgery, University Hospital Lausanne CHUV, Cantonal Hospital Winterthur and Independent
Downloads 147 (502,974)
Citation 4

Abstract:

Loading...

lung cancer; neoadjuvant; chemotherapy; immunotherapy; durvalumab; stage IIIA

2.

Predictive Value of Radiological Response, Pathological Response and Relapse-Free Survival for Overall Survival in Neoadjuvant Immunotherapy Trials: Meta-Analyses of Individual Patient Data

Number of pages: 26 Posted: 02 Sep 2022
Run-Cong Nie, Foping Chen, Mariano Provencio, Yun Wang, Tom van den Ende, H.W.M. van Laarhoven, Shu-Qiang Yuan, Miklos Pless, Stefanie Hayoz, Zhi-Wei Zhou, Yuan-Fang Li, Sacha I. Rothschild and Muyan Cai
Sun Yat-sen University (SYSU) - Department of Gastric Surgery, Sun Yat-sen University (SYSU) - Department of Radiology, Universidad Autónoma de Madrid - Medical Oncology Department, Sun Yat-sen University (SYSU) - Department of Hematologic Oncology, University of Amsterdam - Cancer Center Amsterdam, University of Amsterdam - Cancer Center Amsterdam, Sun Yat-sen University (SYSU) - Department of Gastric Surgery, Cantonal Hospital Winterthur, Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Sun Yat-sen University (SYSU) - Department of Gastric Surgery, Sun Yat-sen University (SYSU) - Department of Gastric Surgery, University of Basel - University Hospital Basel and Sun Yat-sen University (SYSU) - Department of Pathology
Downloads 78 (823,616)

Abstract:

Loading...

neoadjuvant, immune checkpoint inhibitor, surrogate, overall survival

3.

Predictive Value of Radiological Response, Pathological Response and Relapse-Free Survival for Overall Survival in Neoadjuvant Immunotherapy Trials: Pooled Analysis of 29 Clinical Trials

Number of pages: 24 Posted: 17 Jan 2023
Run-Cong Nie, Foping Chen, Mariano Provencio, Yun Wang, Tom van den Ende, H.W.M. van Laarhoven, Shu-Qiang Yuan, Miklos Pless, Stefanie Hayoz, Zhi-Wei Zhou, Yuan-Fang Li, Sacha I. Rothschild and Muyan Cai
Sun Yat-sen University (SYSU) - Department of Gastric Surgery, Sun Yat-sen University (SYSU) - Department of Radiology, Universidad Autónoma de Madrid - Medical Oncology Department, Sun Yat-sen University (SYSU) - Department of Hematologic Oncology, University of Amsterdam - Cancer Center Amsterdam, University of Amsterdam - Cancer Center Amsterdam, Sun Yat-sen University (SYSU) - Department of Gastric Surgery, Cantonal Hospital Winterthur, Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Sun Yat-sen University (SYSU) - Department of Gastric Surgery, Sun Yat-sen University (SYSU) - Department of Gastric Surgery, University of Basel - University Hospital Basel and Sun Yat-sen University (SYSU) - Department of Pathology
Downloads 71 (867,774)

Abstract:

Loading...

surrogate, Overall survival, objective response rate, major pathological response, pathological complete response, relapse-free survival

4.

Role of 18f-Fdg Pet/Ct in the Postoperative Follow-Up in Patients with Stage I-Iii Nsclc: A Retrospective Single-Institution Study

Number of pages: 23 Posted: 02 May 2022
Anna Kaumanns, David König, Marco Cattaneo, Alin Chirindel, Mark Wiese, Michael Tamm, Didier Lardinois, Sacha I. Rothschild and Aljaz Hojski
affiliation not provided to SSRN, University of Basel - University Hospital Basel, University of Basel - Department of Clinical Research, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Basel - Clinic of Pneumology and Pulmonary Cell Research, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel and University of Basel - University Hospital Basel
Downloads 49 (1,074,648)

Abstract:

Loading...

Resectable non-small cell lung cancer, FDG-PET/CT, surveillance, Recurrence, Second curatively intended treatment

5.

Immunotherapy with Pembrolizumab Beyond Progression and Local Ablative Therapy in Oligoprogressive Metastatic Non-Small Cell Lung Cancer

Number of pages: 19 Posted: 06 Mar 2025
Anton Oseledchyk, Leopold Häcker, Andreas M. Schmitt, Till Wallrabenstein, Tobias Finazzi, David König and Sacha I. Rothschild
University of Basel - University Hospital Basel, affiliation not provided to SSRN, University of Basel - University Hospital Basel, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Basel - University Hospital Basel and University of Basel - University Hospital Basel
Downloads 40 (1,196,171)

Abstract:

Loading...

NSCLC, oligoprogressive disease, immune checkpoint blockade, PD-1, treatment beyond progression

6.

First-Line Durvalumab in Patients with Pd-L1 Positive, Advanced Non-Small Cell Lung Cancer (Nsclc) with a Performance Status of 2 (Ps2). Primary Analysis of the Multicenter, Single-Arm Phase Ii Trial Sakk 19/17

Number of pages: 20 Posted: 27 Sep 2023
Michael Thomas Mark, Patrizia Froesch, Katrin Gysel, Sacha I. Rothschild, Alfredo Addeo, Christoph Ackermann, Sabrina Chiquet, Martina Schneider, Karin Ribi, Angela Fischer, Sara Bastian, Roger Von Moos, Markus Joerger and Martin Früh
Kantonsspital Graubünden, Oncology Institute of Southern Switzerland, Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, University of Basel - University Hospital Basel, University of Geneva - Department of Oncology, Spital Thun, Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Kantonsspital Graubünden, Kantonsspital Graubünden, Kantonsspital Graubünden, Cantonal Hospital of St. Gallen and Cantonal Hospital of St. Gallen
Downloads 38 (1,222,651)

Abstract:

Loading...

immunotherapy, first-line, metastatic non-small cell lung cancer, performance status 2

7.

First-line immunotherapy +/- chemotherapy with or without upfront stereotactic radiotherapy (SRT) in patients with Non-Small Cell Lung Cancer (NSCLC) with asymptomatic brain metastases

Number of pages: 26 Posted: 19 Sep 2025
Lorenz Frehner, Sämi Schär, Stefanie Hayoz, Verena Petermichl, Philip Speicher, Sacha I. Rothschild, Laetitia A. Mauti, David König, Tobias Finazzi, Patrizia Froesch, Sabrina Marini, Anna Allemann, Michael Thomas Mark, Wolf-Dieter Janthur, Antonia Stamatiou, Yannis Metaxas, Ekin Ermis, Franca Wagner, Martin Früh and Sabine Schmid
affiliation not provided to SSRN, affiliation not provided to SSRN, Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Kantonsspital St Gallen, affiliation not provided to SSRN, University of Basel - University Hospital Basel, Cantonal Hospital Winterthur, University of Basel - University Hospital Basel, affiliation not provided to SSRN, Oncology Institute of Southern Switzerland, Oncology Institute of Southern Switzerland, affiliation not provided to SSRN, Kantonsspital Graubünden, Department of Oncology/Haematology, Cantonal Hospital Aarau, Lausanne University Hospital, affiliation not provided to SSRN, Varian Medical Systems, affiliation not provided to SSRN, Universitäres Lehrund Forschungsspital and affiliation not provided to SSRN
Downloads 26 (1,372,601)

Abstract:

Loading...

NSCLC, brain metastases, immune checkpoint inhibitors, stereotactic radiotherapy